Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $8.67 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Hermès can regain momentum despite China weakness, Jefferies says